Description: Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
Home Page: www.tecan.com
Seestrasse 103
Männedorf,
8708
Switzerland
Phone:
41 44 922 88 88
Officers
| Name | Title |
|---|---|
| Dr. Achim von Leoprechting Ph.D. | CEO & Member of Management Board |
| Ms. Tania Micki B.A., M.B.A. | CFO & Member of Management Board |
| Mr. Gunter Weisshaar | Sr. VP, Head of Quality Assurance & Regulatory Affairs and Member of Management Board |
| Mr. Andreas Wilhelm | Exec. VP, Gen. Counsel, Sec. of the Board of Directors & Member of Management Board |
| Mr. Martin Brandle | Sr. VP of Corp. Communications & Investor Relations and Member of Management Board |
| Dr. Klaus Lun M.B.A., M.Sc., Ph.D. | Exec. VP, Member of Management Board & Head of the Life Sciences Bus. Division |
| Dr. Ulrich Kanter | Exec. VP, Global Head of Operations & IT and Member of Management Board |
| Mr. Erik Norström B.Sc., M.Sc. | Head of Corp. Devel., Exec. VP & Member of Management Board |
| Dr. Wael Yared | CTO, Exec. VP, Head R&D & Member of the Management Board |
| Mr. Ralf Griebel | Exec. VP, Head of the Partnering Bus. Division & Member of the Management Board |
Exchange: SW
Country: CH
Currency: Swiss Franc (CHF)
| Forward PE: | 32.0513 |
|---|---|
| Trailing PE: | 50 |
| Price-to-Book MRQ: | 4.135 |
| Price-to-Sales TTM: | 4.8045 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3000 |